Multi-Plant Anti-Inflammatory Composition for Chronic Disease Treatment
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for chronic inflammation are limited due to the complex nature of the condition, involving multiple inflammation-inducing molecules and the inhibition of both pro-inflammatory and anti-inflammatory responses, leading to incomplete efficacy in addressing chronic inflammatory diseases such as diabetes and other disorders.
Innovation Solution
A pharmaceutical composition comprising effective amounts of plant species-derived components like Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, and Boswellia sacra, which are administered to inhibit inflammatory responses and reduce C-Reactive protein levels, thereby treating chronic inflammatory diseases and related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current anti-inflammatory treatments are used, then inflammation is suppressed, but both pro-inflammatory and anti-inflammatory responses are inhibited, leading to incomplete efficacy
Solution Approach 1:
The invention uses a combination of multiple plant extracts (Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, Boswellia sacra) rather than a single compound, segmenting the anti-inflammatory action across multiple natural sources to achieve more complete suppression of inflammation while preserving beneficial immune responses
Solution Approach 2:
The patent creates a composite pharmaceutical composition integrating five different plant-derived extracts, each contributing unique anti-inflammatory compounds. This composite approach allows synergistic effects that address the limitations of single-compound treatments by simultaneously targeting multiple inflammatory pathways without completely suppressing the immune system
2Reliability
If plant species-derived components are administered, then inflammation is ameliorated and C-Reactive protein levels are reduced, but the complexity of the composition increases
Solution Approach 1:
The invention merges five distinct plant extracts into a single unified pharmaceutical composition, combining Nigella sativa, Thymus capitatus, Thymus vulgaris, Origanum syriacum, and Boswellia sacra extracts in specific proportions to achieve enhanced anti-inflammatory effects while managing composition complexity through standardized formulation
Solution Approach 2:
Each plant extract in the composition serves multiple functions: Nigella sativa provides thymoquinone for antioxidant and anti-inflammatory effects, Thymus species contribute thymol and carvacrol for antimicrobial and anti-inflammatory activity, Origanum syriacum adds additional phenolic compounds, and Boswellia sacra provides boswellic acids for immune modulation. This multi-functionality reduces the need for separate treatments
Data Source
AI summary
A method of preventing or treating an inflammatory disease and/or conditions associated with inflammation and/or biomarkers associated with inflammation in a subject in need thereof is provided. Also provided are pharmaceutical compositions, articles and foods for the treatment of an inflammatory disease using natural active compounds such as herb and flower extracts.